Cystathionine β-synthase T833C/844INS68 polymorphism: a family-based study on mentally retarded children
© Dutta et al; licensee BioMed Central Ltd. 2005
Received: 16 November 2005
Accepted: 26 December 2005
Published: 26 December 2005
Cystathionine β-synthase (CBS) mediates conversion of homocysteine to cystathionine and deficiency in enzyme activity may lead to hyperhomocysteinemia/homocystinuria, which are often associated with mental retardation (MR). A large number of polymorphisms have been reported in the CBS gene, some of which impair its activity and among these, a T833C polymorphism in cis with a 68 bp insertion at 844 in the exon 8 is found to be associated with mild hyperhomocysteinemia in different ethnic groups.
The present study is aimed at investigating the association between T833C/844ins68 polymorphism and MR. One hundred and ninety MR cases were recruited after psychometric evaluation. Hundred and thirty-eight control subjects, two hundred and sixty-seven parents of MR probands and thirty cardiovascular disorder (CVD) patients were included for comparison. Peripheral blood was collected after obtaining informed written consent. The T833C/844ins68 polymorphism was investigated by PCR amplification of genomic DNA and restriction fragment length polymorphism analysis, followed by statistical analysis.
The genotypic distribution of the polymorphism was within the Hardy-Weinberg equilibrium. A slightly increased genotypic frequency was observed in the Indian control population as compared to other Asian populations. Both haplotype-based haplotype relative risk analysis and transmission disequilibrium test reveled lack of association of the T833C/844ins68 polymorphism with MR; nevertheless, the relative risk calculated was higher (>1) and in a limited number of informative MR families, preferential transmission of the double mutant from heterozygous mothers to the MR probands was noticed (χ2 = 4.00, P < 0.05).
This is the first molecular genetic study of CBS gene dealing with T833C/844ins68 double mutation in MR subjects. Our preliminary data indicate lack of association between T833C/844ins68 polymorphism with MR. However, higher relative risk and biased transmission of the double mutation from heterozygous mothers to MR probands are indicative of a risk of association between this polymorphism with mental retardation.
Cystathionine β-synthase (CBS) catalyzes the condensation of serine and homocysteine to form cystathionine and abnormality in CBS activity is manifested in two major clinical conditions, viz. hyperhomocysteinemia and homocystinuria. Insufficiency in CBS activity may lead to hyperhomocysteinemia , which is considered to be an independent risk factor for arteriosclerosis . In addition to that, since homocysteine is vasculotoxic as well as neurotoxic, hyperhomocysteinemia predisposes to cardiovascular disorder (CVD) and cognitive dysfunction [3, 4]. On the other hand, gross deficiency in CBS activity is associated with homocystinuria, an inborn recessive metabolic disorder . The major pathologic abnormalities associated with homocystinuria include thromboembolism, ectopia lentis, osteoporosis, mental retardation (MR) and other neurological and psychiatric abnormalities . The neurological malfunctioning can be ascribed to the oxidation of excess homocysteine to homocysteic acid, which interacts with the N-methyl-D-aspartate receptor, causing excessive calcium influx and free radical production, thereby leading to neurotoxicity . In addition, MR associated with B12 and folate deficiency could be attributed to the neurotoxic effects of homocysteine since B12 and folate act as co-factors in the homocysteine to methionine remethylation pathway.
The human CBS gene, located at 21q22.3 , is known to have a large number of mutations, the majority of which are missense in nature . Three different nonsense mutants, as well as some insertion, deletion and splice variants have also been identified, some of which are polymorphic in nature. A transition mutation, T833C generating a BsrI restriction site [8, 9] is known to segregate in cis with 844ins68 mutation in exon 8  and is reported to be associated with premature occlusive arterial disease . Ethnic heterogeneity of 844ins68 polymorphism is highly prevalent in African, European and North American populations [9, 12, 13].
Since the T833C/844ins68 double mutation was not detected by Franco et al.  and Pepe et al.  in their studies on some Asian populations (Japanese, Tharu, Chinese and Indonesian), this allele has been projected by Pepe et al.  as a reliable anthropogenetic marker for discriminating between two major human groups – Africans and Asians. Later on, the 844ins68 variant was observed in Han Chinese population with a very low frequency ; however, the T833C polymorphism was not studied. In India, study on T833C mutation revealed 4.76% and 9.99% heterozygotes in control and coronary heart disease patients respectively . In the present study, we have looked into the frequency of the double mutant in control population. We have also investigated the occurrence of this double mutant in MR individuals and a small subset of CVD patients, since hyperhomocysteinemia/homocystinuria is often associated with MR as well as CVD . Familial transmission pattern of the double mutation was analyzed, by haplotype-based haplotype relative risk analysis (HHRR) and transmission disequilibrium test (TDT), using heterozygous parents only.
Our study population consisted of 138 healthy control individuals, 30 CVD patients (average age 53.5 yrs) and 190 MR children (age range 6–8 yrs) along with their parents. The cardiologist (J.M) involved in the study helped in collection of samples from CVD patients. MR cases were selected from the Outpatient Department of Manovikas Kendra Rehabilitation and Research Institute, Kolkata and diagnosed by mental health professionals (child psychiatrist, child psychologist and neurologist) according to the DSM – IV  followed by an IQ assessment with Wechsler Intelligence Scale for Children . Both patients and controls were from different parts of India and belonged to no particular ethnic group. Peripheral blood was collected in EDTA, after obtaining informed written consent from control individuals, CVD patients, and parents of MR probands. Genomic DNA was isolated by standard high salt precipitation method . The Human Ethical Committee of the Institute approved the study protocol.
Restriction fragment length polymorphism (RFLP) analysis
BsrI digestion was carried out for all samples to detect T833C mutation . PCR products (3 μL) were digested at 65°C for 3 hrs. in a final reaction volume of 25 μL, containing 1 U of BsrI (New England Biolabs; NEB) and NEB Buffer 4. Since this point mutation occurs in cis with 844ins68, only the higher allele of 239 bp (A2) was cleaved by BsrI yielding two fragments of 130 bp and 109 bp respectively (Fig 1); wild type allele of 171 bp (A1), however, remained undigested.
Frequency of the T833C/844ins68 polymorphism in the control population and patients was calculated for the Hardy-Weinberg equilibrium. Haplotype-based haplotype relative risk (HHRR) analysis  as well as transmission disequilibrium test (TDT)  was used to ascertain association between MR and transmission of the double mutation. For TDT, trios with at least one parent having heterozygous genotype were selected.
Global variation of CBS 844ins68 polymorphism in control individuals.
Tsai et al. 
Kluijtmans et al. 
Franco et al. 
Pepe et al. 
Pepe et al. 
Pepe et al. 
Pepe et al. 
Pepe et al. 
Linnebank et al. 
Chinese (Southern China)
Zhang & Dai 
Grossmann et al. 
Chinese (Northern China)
Li et al. 
Distribution of CBS T833C/844ins68 polymorphism in different groups.
No of chromosome
No of mutants
Mutant allele frequency ± SE
0.0398 ± 0.0117
0.0166 ± 0.0166
0.0316 ± 0.0089
Parents of probands
0.028 ± 0.0071
HHRR and TDT Analysis for the CBS T833C/844ins68 polymorphism in nuclear families with MR probands.
Relative risk (RR)
Transmission pattern of CBS T833C/844ins68 from mother to MR proband.
HHRR analysis (all mothers)
HHRR analysis (heterozygous mothers only)
The present finding of 11 out of 138 Indian control individuals with the T833C/844ins68 polymorphism reveal a higher percentage of heterozygotes (7.97%) as compared to the Chinese control population (Table I); but, this value is significantly lower than those quoted for Sub-Saharan population . Two earlier independent studies on Japanese and other Asian populations failed to detect the mutated allele [13, 14] and this led to the proposal that this unique double mutation could be used as a reliable anthropogenetic marker for differentiating Asians and Africans. However, the validity of the proposal is questioned by subsequent findings of the 844ins68 polymorphism in different Chinese populations [15, 25] and T833C transition mutation in Indian population [16, 26]. The present study clearly demonstrates that the T833C/844ins68 polymorphism may not be suitable as an anthropogenetic marker for differentiating Asians and Africans.
Among Indians, presence of T833C heterozygote has been reported in 1 out of 21 (4.76%)  and 3 out of 100 (3%)  control individuals. However, in both studies the association of 844ins68 mutation with the T833C transition mutation has not been mentioned, while in the present investigation we have observed invariable segregation of these two mutations in cis, which is consistent with earlier observations [10, 13, 14, 22].
Hyperhomocysteinemia is hypothesized as an independent risk factor for CVD [22, 27] and the 844ins68 variant was previously reported to be associated with premature occlusive arterial disease . A recent article on Chinese congenital heart disease (CHD) patients have shown that the 844ins68 could be a risk factor for CHD, and the insertion especially in mothers could increase the risk in offspring . On the other hand, the findings of Zhang and Dai  on adult Chinese patients have suggested that the 844ins68 could provide protection to vascular thromboembolic disease. The mutant allele frequencies among the Indian controls and the CVD patients are 0.0398 and 0.0166 respectively (Table II) and no association was observed between T833C/844ins68 polymorphism and CVD. Heterozygous T833C/844ins68 alleles were observed at higher percentage in Indian CVD patients (3.33%) as compared to Chinese ischemic patients (~1%). The lower value of 3.33% for CVD patients as compared to that of the control (7.97%) seems to support the idea of a possible protective role of the double mutation to vascular thromboembolic disease, as proposed by Zhang and Dai ; however, such a conclusion is not called for due to the relatively small CVD sample size in the present study.
While the T833C mutation results in Ile278Thr change in the mutant protein, in the case of T833C/844ins68, the 68 bp insertion results in an alternative splice site generating mostly wild type mRNA with traces of another transcript, detectable only in the nucleus [9, 12]. This accounts for the rescue of the transition mutation at 278 in the case of the double mutant [9, 10]. However, these observations cannot account for the conflicting reports on the association between cardiovascular disease in different ethnic populations and the mutant allele [28, 29]. Case control studies showed that this double mutation might be a neutral polymorphism in the CBS gene and splicing of the intron 7 eliminates the mutant allele carrying the T833C . On the other hand, in Northern Europe, the T833C mutation is common in patients presenting clinically with homocystinuria and is associated with a B6-responsive phenotype [22, 28].
The CBS T833C/844ins68 polymorphism has been reported in homozygous condition, with a very low frequency, from American black artheroslerosis patients . We have failed to observe any subject homozygous for the mutation in our study group, which possibly points towards the deleterious effect of this mutation in homozygous condition.
The present finding of preferential transmission of T833C/844ins68 polymorphism to the MR proband from the heterozygous mother is the first evidence of any association of CBS gene with MR, although the association of hyperhomocysteinemia/homocystinuria with psychiatric manifestations including MR is well established [3, 4, 30]. Among different markers for cobalamine/folate status, plasma homocysteine showed the best association with aging related neuropsychiatric dysfunction  and an earlier investigation revealed that the CBS 844ins68 allele frequency was lower in children with high IQ as compared to those with average IQ . In the present investigation, though the HHRR and TDT analysis failed to show any significant transmission of the mutant allele to the MR probands (χ2 = 1.714 and 1.00 respectively), the relative risk (RR = 1.346) calculated showed a risk of MR associated with transmission of the mutant allele. The preferential transmission of T833C/844ins68 polymorphism from the heterozygous mother to the MR proband (χ2 = 4.00, P = 0.0455) also supports the above possibility.
This is the first report on CBS T833C/844ins68 polymorphism in association with MR and to the best of our knowledge, this is also the first information on the occurrence of the CBS double mutation in the Indian population. Our preliminary data indicate lack of significant association between T833C/844ins68 polymorphism with MR; however, the relative risk calculated and the preferential transmission of the double mutation from informative mothers to MR probands do suggest a risk of association of this polymorphism with MR and warrants further investigation.
SD (JRF, DBT Grant) was responsible for acquisition of data and analysis and drafting the article. SS performed psychometric analysis and clinical diagnosis, intellectual contribution. AC helped in psychological evaluation and IQ determination. PKG was responsible for neurological investigations and intellectual contribution. JG diagnosed the CVD cases. MS revised the manuscript critically. KM was responsible for concept and study design, interpretation of data and revising the article critically. Final manuscript was approved by all authors.
List of Abbreviations used
- MR (Mental retardation):
CBS (Cystathionine β-synthase), CVD (cardiovascular disorder), HHRR (haplotype-based haplotype relative risk), TDT (transmission disequilibrium test), CHD (congenital heart disease).
Authors are thankful to the families who have participated in the study. This work was partly sponsored by a grant from the Department of Biotechnology, Government of India; Grant No. BT/PR4269/SPD/11/478/2003.
- Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Homocysteinemia: A risk factor for vascular disease. N Eng J Med. 1991, 325: 967-View ArticleGoogle Scholar
- Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc. 1995, 274: 1049-57. 10.1001/jama.274.13.1049.View ArticleGoogle Scholar
- Carson NA, Neill DW: Metabolic abnormalities detected in a survey of mentally backward individuals in North Ireland. Arch Dis Child. 1962, 37: 505-13.PubMed CentralView ArticlePubMedGoogle Scholar
- Mudd SH, Levy HL, Kraus JP: From Disorders of transulfuration. The metabolic and molecular bases of inherited disease. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B. 2001, New York: McGraw-Hill, 2007-2056. 8Google Scholar
- Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, Arnelle DR, Stamler JS: Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci. 1997, 94: 5923-28. 10.1073/pnas.94.11.5923.PubMed CentralView ArticlePubMedGoogle Scholar
- Munke M, Kraus JP, Ohura T, Francke U: The gene for cystathionine β-synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17. Am J Hum Genet. 1988, 42: 550-59.PubMed CentralPubMedGoogle Scholar
- Kraus JP, Oliveriusova J, Sokolova J, Kraus E, Vlcek C, de Franchis R, Maclean KN, Bao L, Bukovska G, Patterson D, Paces V, Ansorge W, Kozich V: The human cystathionine β-synthase (CBS) gene: complete sequence, alternative splicing, and polymorphisms. Genomics. 1998, 52: 312-24. 10.1006/geno.1998.5437.View ArticlePubMedGoogle Scholar
- Kozich V, Kraus JP: Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine β-synthase deficiency. Hum Mutat. 1992, 1: 113-23. 10.1002/humu.1380010206.View ArticlePubMedGoogle Scholar
- Tsai MY, Bignell M, Schwichtenberg K, Hanson Q: High prevalence of a mutation in the cystathionine β-synthase gene. Am J Hum Genet. 1996, 59: 1262-67.PubMed CentralPubMedGoogle Scholar
- Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G: The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet. 1995, 56: 1324-33.PubMed CentralPubMedGoogle Scholar
- Orendac M, Muskova B, Richterova F, Zvarova J, Stefek M, Zaykova E, Stribrny J, Hyanek J, Kraus JP, Kozich V: Mutation C677T in MTHFR gene and polymorphism 844ins68 in the CBS gene: Risk factor for peripheral arterial occlusive disease?. Neth J Med. 1998, S47-Suppl 52
- Sperandeo MP, de Franchis R, Andria G, Sebastio G: A 68-bp insertion found in a homocystinuric patient is a common variant and is skipped by alternative splicing of the cystathionine β-synthase mRNA. Am J Hum Genet. 1996, 59: 1391-93.PubMed CentralPubMedGoogle Scholar
- Franco RF, Elion J, Lavinha J, Krishnamoorthy R, Tavella MH, Zago MA: Heterogeneous ethnic distribution of the 844ins68 in the cystathionine β-synthase gene. Hum Hered. 1998, 48: 338-42. 10.1159/000022826.View ArticlePubMedGoogle Scholar
- Pepe G, Camacho Vanegas O, Rickards O, Giusti B, Comeglio P, Brunelli T, Marcucci R, Prisco D, Gensini GF, Abbate R: World distribution of the T833C/844INS68 CBS in cis double mutation: a reliable anthropological marker. Hum Genet. 1999, 104: 126-29. 10.1007/s004390050924.View ArticlePubMedGoogle Scholar
- Zhang G, Dai G: Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb Res. 2001, 104: 187-95. 10.1016/S0049-3848(01)00352-8.View ArticlePubMedGoogle Scholar
- Nair KG, Nair SR, Ashavaid TF, Dalal JJ, Eghlim FF: Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population. J Assoc Physicians India. 2002, 9-15. Suppl 50
- American Psychiatric Association: Diagnostic and statistical manual of mental disorders, Text Revised: DSM-IV, Washington, D.C. 1994Google Scholar
- Wechsler D: Wechsler Intelligence Scale for Children-Third Edition: Manual. 1991, San Antonio, TX: Psychological CorporationGoogle Scholar
- Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988, 16: 1215-PubMed CentralView ArticlePubMedGoogle Scholar
- Terwilliger JD, Ott J: A haplotype-based "haplotype relative risk" approach to detecting allelic association. Hum Heredity. 1992, 42: 337-46.View ArticlePubMedGoogle Scholar
- Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993, 52: 506-16.PubMed CentralPubMedGoogle Scholar
- Kluijtmans LAJ, Boers GHJ, Trijbels FJM, Van Lith-Zanders HMA, van den Heuvel LPWJ, Blom HJ: A common 844ins68 insertion variant in the cystathionine β-synthase gene. Biochem and Mol Med. 1997, 62: 23-25. 10.1006/bmme.1997.2623.View ArticleGoogle Scholar
- Linnebank M, Homberger A, Junker R, Nowak-Goettl U, Harms E, Koch HG: High prevalence of the I278T mutation of the human cystathionine β-synthase detected by a novel screening application. Thromb Haemost. 2001, 85: 986-88.PubMedGoogle Scholar
- Grossmann R, Schwender S, Geisen U, Schambeck C, Merati G, Walter U: CBS 844ins68, MTHFR TT677 and EPCR 4031ins23 genotypes in patients with deep-vein thrombosis. Thromb Res. 2002, 107: 13-15. 10.1016/S0049-3848(02)00187-1.View ArticlePubMedGoogle Scholar
- Li Y, Cheng J, Zhu WL, Dao JJ, Yan LY, Li MY, Li SQ: Study of serum Hcy and polymorphisms of Hcy metabolic enzymes in 192 families affected by congenital heart disease. Beijing Da Xue Xue Bao. 2005, 37: 75-80.PubMedGoogle Scholar
- Khare A, Ghosh K, Shetty S, Kulkarni B, Mohanty D: Combination of thrombophilia markers in acute myocardial infarction of the young. Ind J Med Sci. 2004, 58: 381-86.Google Scholar
- Boers GHJ, Smals AGH, Trijbels FJM, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PWC: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Eng J Med. 1985, 313: 709-15.View ArticleGoogle Scholar
- Gaustadnes M, Ingerslev J, Rutiger N: Prevalence of congenital homocystinuria in Denmark. N Engl J Med. 1999, 340: 1513-10.1056/NEJM199905133401915.View ArticlePubMedGoogle Scholar
- Kluijtmans LAJ, Boers GHJ, Kraus JP, van den Heuvel LPWJ, Cruysberg JRM, Trijbels FJM, Blom HJ: The molecular basis of Cystathionine β-Synthase deficiency in Dutch patients with homocystinuria: Effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet. 1999, 65: 59-67. 10.1086/302439.PubMed CentralView ArticlePubMedGoogle Scholar
- Abbott MH, Folstein SE, Abbey H, Pyeritz RE: Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Am J Med Genet. 1987, 26: 959-69. 10.1002/ajmg.1320260427.View ArticlePubMedGoogle Scholar
- Robins Wahlin RB, Wahlin A, Winblad B, Backamn L: The influence of serum vitamin B12 and folate status on cognitive functioning in very old age. Biol Psychol. 2001, 56: 247-65. 10.1016/S0301-0511(01)00079-5.View ArticlePubMedGoogle Scholar
- Barboux S, Plomin R, Whitehead AS: Polymorphisms of genes controlling homocysteine/folate metabolism and cognitive function. Neuroreport. 2000, 11: 1133-36.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.